Deepak Nitrite Q1 FY27: Record profitability, Phenolics strength, and the next capex cycle

Deepak Nitrite reported its highest-ever quarterly performance in Q1 FY27. Consolidated total revenue was INR 2,592 crore, up 35 percent year on year and 22 percent quarter on quarter. EBITDA rose to INR 554 crore, up 159 percent year on year, with EBITDA margin expanding to 21 percent from 11 percent in Q1 FY26. PAT came in at INR 345 crore, up 207 percent year on year, and PAT margin improved to 13 percent.

Management attributed the performance to a combination of improving market conditions and internal execution. The quarter was described as volatile, shaped by geopolitical tensions, supply-chain disruption, and feedstock availability and pricing uncertainty. The company highlighted proactive procurement, disciplined commercial execution, steady utilisation, favourable product mix, and integration benefits as key drivers.

Segment snapshot: Phenolics led, Advanced Intermediates improved

The consolidated segmental picture was clear. Phenolics delivered the highest-ever quarterly performance, while Advanced Intermediates showed a meaningful sequential recovery.

Phenolics revenue from operations was INR 1,775 crore in Q1 FY27, up 36 percent year on year and 24 percent quarter on quarter. Segment EBIT rose to INR 418 crore, up 254 percent year on year, with EBIT margin expanding to 24 percent. Management linked the strength to firm domestic realisations, stable offtake, proactive feedstock management, and process optimisation and debottlenecking.

Advanced Intermediates (AI) revenue from operations was INR 804 crore, up 33 percent year on year and 14 percent quarter on quarter. Segment EBIT was INR 67 crore, up 89 percent year on year and 100 percent sequentially, with EBIT margin at 8 percent. Management commentary focused on improved realisations, product mix, and increasing synergies from backward integration initiatives.

Financial summary (Consolidated)

Integration, commissioning pipeline, and execution signals

A recurring theme across the investor presentation and concall was structural strengthening through integration. Management stated that the ammonia-to-amines integration chain has been completed and stabilised, and positioned the company as “a nitrogen company that nitrates” rather than one that buys nitric acid. In the same context, management said that in-house nitric acid enhances cost competitiveness and enables chemistries that are harder to execute otherwise.

The quarter also served as a bridge into a commissioning-heavy period. In the concall, management said MIBK and MIBC would be commissioned along with acetophenone in August, with the rest of related projects commissioned within Q2. Management stated that product quality for MIBK and MIBC has been approved and appreciated, and that pre-commissioning runs already achieved targeted raw material and utility norms. The company also noted that certain projects faced pre-commissioning delays due to contractual manpower unavailability and a natural gas shortage, but indicated the overall ramp-up was planned over a few months.

In Phenolics, management highlighted process control as a key lever behind higher output without compromising quality. They cited investment in advanced process controls and indicated an additional debottlenecking investment of about INR 70 crore aimed at moving towards a phenol capacity of around 4 lakh tonnes.

The large bet: Polycarbonate platform and feedstock security

The biggest strategic initiative remains the integrated polycarbonate program. The presentation states India’s first integrated polycarbonate plant with capacity of 165,000 MT per year, and a plan to build integration from Cumene to Phenol to Acetone to Polycarbonate. The project update notes dismantling of a plant in Stade, Germany with partial shipments received at Dahej, contractor mobilisation with civil work underway in India, and completion of ordering for major OSBL equipment. The presentation states total commitment for the polycarbonate project is around INR 2,900 crore.

In the concall, management discussed the wider propylene and polycarbonate project with a capex size of INR 11,500 crore, funded by a 60:40 debt to equity structure. The Group CFO stated the entire debt has been tied up, and estimated peak debt including working capital at around INR 8,000 crore to INR 8,500 crore, while maintaining that debt to equity would remain comfortable and not cross 1.

Alongside this, the presentation disclosed a long-term HyCo contract to set up a dedicated on-site plant to ensure reliable supply of critical raw materials, with commissioning targeted in 2028 in line with the DCTL polycarbonate project timeline.

Costs, energy transition, and the operating backdrop

Management repeatedly described the operating environment as uncertain. The presentation listed risks including aggressive global pricing, logistics volatility, feedstock constraints, and energy cost spikes, along with potential demand softness. The company’s strategic response emphasized backward integration, long-term sourcing agreements, diversification of procurement, and captive and renewable energy initiatives.

On energy transition, the responsible chemistry scorecard mentions a target of 60 to 70 percent renewable energy mix progressively from FY27 and states that short and long-term renewable power purchase agreements are expected to save an estimated INR 20 crore annually. The presentation also notes that renewable energy investments delivered about INR 4.5 crore in cost savings during Q1 FY27.

Takeaways

Q1 FY27 showcased operating leverage and the payoff from integration and disciplined execution, particularly in Phenolics where profitability reached record levels. Advanced Intermediates improved sequentially, supported by stabilisation of backward integrated assets and better product mix.

The next phase is defined by execution. Near-term commissioning of MIBK, MIBC and acetophenone, continued debottlenecking in Phenolics, and the much larger polycarbonate platform build-out will shape both earnings durability and balance sheet trajectory. Management’s disclosures on funding tie-ups, peak debt expectations, and project timelines provide a framework for tracking delivery through FY28-29.